Allarity Therapeutics, Inc. SEC filings ALLR
Allarity Therapeutics, Inc. has 403 filings in SEC EDGAR's recent list, going back to May 27, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 9, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | May 14, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | May 11, 2026 | Jan 28, 2026 |
| 3 | Initial insider ownership | May 11, 2026 | Jun 10, 2025 |
| 4 | Insider transaction | May 7, 2026 | Jan 28, 2026 |
| 4/A | Ownership document | Apr 30, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Apr 30, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 3 | Initial insider ownership | Jul 14, 2025 | Jul 1, 2025 |
| 4/A | Form 4/a | Jan 24, 2025 | Jan 22, 2025 |
| 4/A | Form 4/a | Jan 24, 2025 | Jan 22, 2025 |
| 4/A | Form 4/a | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| 3 | Initial insider ownership | Oct 1, 2024 | Sep 30, 2024 |
| 3 | Initial insider ownership | Sep 18, 2024 | Sep 12, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 29, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 29, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| 3 | Initial insider ownership | Aug 28, 2023 | Aug 1, 2023 |
| 3 | Initial insider ownership | Aug 2, 2023 | Aug 1, 2023 |
| SC 13G | Ownership over 5% (passive) | Jul 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Apr 28, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Mar 2, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 25, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2023 | — |
| 3 | Initial insider ownership | Oct 3, 2022 | Oct 1, 2022 |
| 4 | Insider transaction | Jul 14, 2022 | Jun 27, 2022 |
| 3 | Initial insider ownership | Jul 11, 2022 | Jul 7, 2022 |
| 3 | Initial insider ownership | Jul 6, 2022 | Jun 29, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 20, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 27, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Dec 22, 2021 | — |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
| 3 | Initial insider ownership | Dec 22, 2021 | Dec 20, 2021 |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALLR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1860657
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.